featured
Persistence and Adherence With Mirabegron vs Antimuscarinic Agents in Patients With Overactive Bladder
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Persistence and Adherence With Mirabegron Versus Antimuscarinic Agents in Patients With Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice
Eur Urol 2017 Sep 01;72(3)389-399, CR Chapple, J Nazir, Z Hakimi, S Bowditch, F Fatoye, F Guelfucci, A Khemiri, E Siddiqui, A WaggFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.